 |
| 3rd Annual Drug Discovery Partnership: Filling the Pipeline |
| Integrating Private-Public Efforts to Treat Severely Unmet Medical Needs |
| |
| October 17-18, 2011 |
| Hilton Boston Logan Airport, Boston, MA |
| |
|
|
|
 |
|
We are proud to present our 3rd Annual Drug Discovery Partnership: Filling the Pipeline Conference!
Early stage drug discovery is a key bottleneck in the pipeline to find novel drugs. With key products suffering patent expiration in coming years, the need for new approaches to accelerate development of new chemical entities to treat severely unmet medical needs is more urgent than ever. Much of this work can only be done through the collaborative work of public and private industry. More than ever, drug discovery professionals from across the industry need to come together to share their technology, insight and experiences to help fill the quickly drying pipeline of new and effective drugs!
This drug discovery conference brings together pharmaceutical companies, small biotechnology enterprises, government agencies, for-profit and not-for profit research institutions to exchange ideas, make connections and discuss opportunities to create an environment that will foster pharmaceutical innovation
|
Hot topics of discussion during this two day conference to include:
- The Next Ten Years: Trends in the Developing Industry
- Pre-competitive Collaboration: Sharing Data to Increase Predictability
- Maximizing the Small Biotech's Potential: Utilizing Resources, Boosting Visibility, and Ensuring Sustainability
- The Role of Disease Foundations in Early Drug Discovery
- International Partnerships and the Globalization of Drug Discovery
- Legal Insight: Negotiating Contracts, Navigating IP Issues, and Developing Sustainable Relationships
And much more! |
| |
| This event will be co-located with our 3rd Annual Drug Discovery: Easing the Bottleneck |
| |
|
|
| |
Dr. Krishna Balakrishnan, Technology Transfer Manager, NIH
Dr. Rekha Paleyanda, Senior Business Strategy and Licensing Manager, Partners HealthCare, Research Ventures and Licensing, Massachusetts General Hospital
Dr. Cory Acuff, Senior Licensing Associate, Emory University
Robert Selliah, PhD, Founder & CEO, American MedChem Nonprofit Corporation
Dr. Andrew Napper, Head, High-Throughput Screening & Drug Discovery Lab, Nemours Center for Childhood Cancer Research
Dr. Justin Boyd, Scientist/CSO & Co-Founder, Brigham & Women's Hospital/Chattanooga Research Institute
Dr. Jerome Baudry, Assistant Professor, Center for Molecular Biophysics, University of Tennessee/Oak Ridge National Laboratories
Dr. Oliver Hofmann, Associate Director, Bioinformatics Core, Research Scientist Dept. of Biostatistics, Harvard School of Public Health
Dr. Melvin Reichman, Director, LIMR Chemical Genomics Center
Dr. Christopher Moxham, Senior Research Advisor, Group Leader, Eli Lilly
Dr. Nurjana Bachman, Business Development Manager, Children's Hospital of Boston
Dr. Erin Skoda, Research Project Manager, University of Pittsburgh
Dr. Masha Hareli, President, AWIS Boston
Dr. Heidi Rehm, Director, Laboratory for Molecular Medicine, Partners Healthcare Center for Personalized Genetic Medicine
Monique Yoaquim-Turk, Technology Development Manager, Children's Hospital of Boston
Dr. Chris Waller, Senior Director of Enterprise Architecture, Pfizer
Dr. Jean-Claude Bradley, Professor and E-Learning Coordinator, Drexel University
Stella Stergiopoulos, Project Manager, Tufts Center for the Study of Drug Development
Dr. Jit Patel, Director, Head of Neuroscience Preclinical Business Development, AstraZeneca
Dr. Albert Giovenella, Adjunct Assistant Professor Of Medicine, and Drug Development Analyst, Dept of Medicine, Division of Geriatrics, University of Pennsylvania School of Medicine
Dr. Shannan HoSui, Research Associate, Department of Biostatistics, Harvard School of Public Health
Dr. Alvin Shih, Director of Orphan and Genetic Diseases, Pfizer
Dr. Stephen Chang, Vice President of Research and Development, New York Stem Cell Foundation
Andrew Koopman, Manager, New Venture Development, NYU Office of the Industrial Liason
Dennis M Godek, MD. Partner, MediSynergics LLC
Dr. Yali Friedman, Chief Editor and Publisher, Journal of Commercial Biotechnology
Peter Corless, Partner, Edwards Wildman Palmer LLP
Kathleen Carr, Partner, Edwards Wildman Palmer LLP
Mary Jo Lamberti, PhD, Senior Project Manager, Tufts Center for the Study of Drug Development
Dr. Antony Williams, VP Strategic Development, ChemSpider, Royal Society of Chemistry
Dr. Kathleen Seyb, Senior Scientist, Brigham and Women's Hospital
Dr. Eva Lee, Center for Operations Research in Medicine and HealthCare, Georgia Institute of Technology |
| |
|
| |
Conference Registration Prices: |
|
| |
| |
Before 9/16/11 |
After 9/16/11 |
Service Providers
(including CROs, Legal, Consulting Firms, Vendors, etc.) |
$795 |
$995 |
| * Pharmaceutical Companies - $495 |
|
| |
Group Discounts:
Register 3 people and receive 10% off ***
Register 4 people and receive 15% off ***
Register 5 people or more and receive 20% off *** |
|
***Registrations must be made online on the same date. Discount will be applied after all registrants have been received. |
| |
|
|
If you'd like to be invoiced, please submit your contact details on the registration page and select "Please invoice me" at the bottom of the page.
If you are interested in sponsorship, exhibiting, or speaking opportunities, please call 212-532-9898 or email information@opalevents.org |
|
* TERMS & CONDITIONS
Subject to approval. To qualify you must be currently employed by a non-vendor company. Eligibility will be verified by conference producer. Opal reserves the right to allocate places and to refuse applications. |
|
| |
|
|
| |
| Opal Events' 3rd Annual Drug Discovery Partnership: Filling the Pipeline 2011 conference has been researched and developed specifically for; Pharmaceuticals, Biotech, Academia, Foundation, Technology Companies, and CROs' VP/ Director/ Manager/ Faculty Advisor of: |
- External Research Collaboration
- Scientific Affairs
- Business Development
- Partnership/ Alliance Management
- Office of Technology Transfer
- Academic Screening Facilities
- School of Medicine/ Life Sciences/ Pharmacy
- Grants Manager
- Program Office
|
- Research & Development
- Analytical/ Medicinal Chemistry
- Sample/ Compound Management
- Assay Development
- Lead Discovery/ Optimization
- High Throughput Screening (HTS)
- Automation
ADMET
|
University faculty advisors, department heads and managers from below will also benefit:
|
- Office of Technology Transfer
- School of Medicine/ Life Sciences/ Pharmacy
- Grants Manager
- Program Office
- Chemistry Departments
|
|
|
|
| |
|
| |
|
|
| |
 |
| |
|
|
| |
 |
| |
| |
|
|
|
|
|
